GLP-1 medications are transforming how we think about chronic disease management and, more importantly, prevention. Ongoing research has found them to be effective in the prevention or treatment of diabetes, heart attacks and strokes, kidney disease, liver disease, sleep apnea, and more.

The post Diabetes Eradication? The New Chronic Condition Care Playbook and How GLP-1s Are Changing the Game appeared first on MedCity News.

By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits.

The post Study: Why Quick Fixes Don’t Work in Workplace Wellness appeared first on MedCity News.

Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum.

The post Considering Covering GLP-1s? Here’s What You Need to Know appeared first on MedCity News.

Lifestyle is equally important for long-term success. A good behavior-change program can benefit many people with chronic conditions – whether by impacting clinical outcomes, improving quality of life, or helping to lower long-term health-care costs.

The post GLP-1s Can Improve Many Common Health Issues, but They’re Not Magic appeared first on MedCity News.

A healthy and inclusive workplace environment needs flexible solutions that are personalized to all lifestyles, work schedules, cultures and food preferences.

The post The Skeleton in the Diet Closet: Why Quick-Fix Diets Like Keto Are Unrealistic, Impractical and Downright Discriminatory in the Workplace appeared first on MedCity News.

A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.

The post Downside of One-Size-Fits-All: Rethinking Weight-Loss Medications Strategy appeared first on MedCity News.